Pharma Total Revenue vs Total Assets Analysis

0RC6 Stock   74.70  1.12  1.52%   
Pharma Mar financial indicator trend analysis is much more than just breaking down Pharma Mar SAU prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharma Mar SAU is a good investment. Please check the relationship between Pharma Mar Total Revenue and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Pharma Mar SAU. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Revenue vs Total Assets

Total Revenue vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharma Mar SAU Total Revenue account and Total Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Pharma Mar's Total Revenue and Total Assets is 0.5. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Total Assets in the same time period over historical financial statements of Pharma Mar SAU, assuming nothing else is changed. The correlation between historical values of Pharma Mar's Total Revenue and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Pharma Mar SAU are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Revenue i.e., Pharma Mar's Total Revenue and Total Assets go up and down completely randomly.

Correlation Coefficient

0.5
Relationship DirectionPositive 
Relationship StrengthWeak

Total Revenue

Total revenue comprises all receipts Pharma Mar SAU generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Total Assets

Total assets refers to the total amount of Pharma Mar assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pharma Mar SAU books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Pharma Mar's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharma Mar SAU current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Pharma Mar SAU. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Tax Provision is likely to gain to about 10.1 M in 2025, whereas Selling General Administrative is likely to drop slightly above 2.7 M in 2025.
 2022 2023 2024 2025 (projected)
Gross Profit182.7M148.5M166.7M117.0M
Total Revenue196.3M158.2M174.9M148.3M

Pharma Mar fundamental ratios Correlations

-0.770.820.590.890.48-0.830.710.20.80.20.570.950.06-0.280.250.30.81-0.420.420.99-0.68-0.68-0.130.590.73
-0.77-0.73-0.11-0.79-0.530.91-0.76-0.09-0.8-0.13-0.31-0.85-0.340.510.1-0.05-0.830.550.03-0.780.830.760.37-0.72-0.61
0.82-0.730.650.620.11-0.680.72-0.030.620.030.460.83-0.23-0.110.420.140.72-0.60.560.85-0.7-0.60.030.320.88
0.59-0.110.650.32-0.07-0.180.240.10.210.180.330.44-0.510.190.520.360.28-0.120.770.59-0.11-0.110.28-0.080.58
0.89-0.790.620.320.65-0.840.770.250.740.140.510.830.2-0.2-0.080.490.79-0.430.060.86-0.76-0.76-0.040.630.49
0.48-0.530.11-0.070.65-0.50.40.550.430.290.070.450.55-0.6-0.490.420.35-0.13-0.390.45-0.44-0.53-0.460.730.02
-0.830.91-0.68-0.18-0.84-0.5-0.69-0.05-0.96-0.14-0.38-0.9-0.440.44-0.06-0.01-0.920.41-0.11-0.830.760.830.35-0.75-0.57
0.71-0.760.720.240.770.4-0.690.330.53-0.060.530.71-0.05-0.040.080.390.68-0.910.150.71-0.95-0.70.130.420.65
0.2-0.09-0.030.10.250.55-0.050.330.010.390.070.040.15-0.22-0.180.43-0.01-0.3-0.10.15-0.310.08-0.130.19-0.01
0.8-0.80.620.210.740.43-0.960.530.010.210.30.870.49-0.510.14-0.130.9-0.260.180.79-0.59-0.75-0.450.710.5
0.2-0.130.030.180.140.29-0.14-0.060.390.21-0.280.030.22-0.45-0.30.070.090.19-0.150.090.070.24-0.430.06-0.16
0.57-0.310.460.330.510.07-0.380.530.070.3-0.280.57-0.260.280.580.330.25-0.410.560.59-0.51-0.40.360.240.71
0.95-0.850.830.440.830.45-0.90.710.040.870.030.570.19-0.370.290.10.85-0.450.390.97-0.72-0.8-0.250.720.78
0.06-0.34-0.23-0.510.20.55-0.44-0.050.150.490.22-0.260.19-0.68-0.36-0.370.280.2-0.460.03-0.11-0.27-0.760.74-0.25
-0.280.51-0.110.19-0.2-0.60.44-0.04-0.22-0.51-0.450.28-0.37-0.680.330.38-0.35-0.090.32-0.280.130.250.97-0.67-0.03
0.250.10.420.52-0.08-0.49-0.060.08-0.180.14-0.30.580.29-0.360.33-0.220.05-0.170.950.3-0.05-0.020.26-0.080.65
0.3-0.050.140.360.490.42-0.010.390.43-0.130.070.330.1-0.370.38-0.22-0.03-0.23-0.030.25-0.3-0.190.55-0.080.06
0.81-0.830.720.280.790.35-0.920.68-0.010.90.090.250.850.28-0.350.05-0.03-0.440.150.81-0.68-0.75-0.250.580.52
-0.420.55-0.6-0.12-0.43-0.130.41-0.91-0.3-0.260.19-0.41-0.450.2-0.09-0.17-0.23-0.44-0.17-0.440.840.5-0.21-0.17-0.59
0.420.030.560.770.06-0.39-0.110.15-0.10.18-0.150.560.39-0.460.320.95-0.030.15-0.170.45-0.08-0.060.3-0.090.7
0.99-0.780.850.590.860.45-0.830.710.150.790.090.590.970.03-0.280.30.250.81-0.440.45-0.69-0.71-0.130.60.77
-0.680.83-0.7-0.11-0.76-0.440.76-0.95-0.31-0.590.07-0.51-0.72-0.110.13-0.05-0.3-0.680.84-0.08-0.690.72-0.02-0.52-0.65
-0.680.76-0.6-0.11-0.76-0.530.83-0.70.08-0.750.24-0.4-0.8-0.270.25-0.02-0.19-0.750.5-0.06-0.710.720.13-0.64-0.52
-0.130.370.030.28-0.04-0.460.350.13-0.13-0.45-0.430.36-0.25-0.760.970.260.55-0.25-0.210.3-0.13-0.020.13-0.630.07
0.59-0.720.32-0.080.630.73-0.750.420.190.710.060.240.720.74-0.67-0.08-0.080.58-0.17-0.090.6-0.52-0.64-0.630.34
0.73-0.610.880.580.490.02-0.570.65-0.010.5-0.160.710.78-0.25-0.030.650.060.52-0.590.70.77-0.65-0.520.070.34
Click cells to compare fundamentals

Pharma Mar Account Relationship Matchups

Pharma Mar fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets330.3M368.4M393.3M340.5M349.6M281.1M
Short Long Term Debt Total56.7M49.3M42.6M43.7M51.1M80.7M
Other Current Liab57.1M45.4M55.1M51.9M31.9M21.6M
Total Current Liabilities94.9M86.3M97.3M95.9M82.7M81.4M
Total Stockholder Equity102.7M177.9M223.0M193.4M208.4M218.8M
Property Plant And Equipment Net25.5M30.6M34.7M47.6M59.1M37.1M
Net Debt(39.5M)(64.0M)(107.2M)(16.4M)(12.2M)(11.6M)
Retained Earnings41.9M121.3M156.5M142.2M168.4M176.8M
Accounts Payable21.0M26.9M27.5M29.2M38.7M29.0M
Cash96.2M113.3M149.8M60.0M63.2M54.1M
Non Current Assets Total84.6M73.2M118.1M88.6M99.4M73.7M
Non Currrent Assets Other100.2M89.4M33.5M1.5M92.1M96.7M
Cash And Short Term Investments195.5M201.9M182.4M162.6M154.5M103.2M
Common Stock Shares Outstanding18.3M18.1M18.1M17.9M17.6M19.8M
Liabilities And Stockholders Equity330.3M368.4M393.3M340.5M349.6M281.1M
Non Current Liabilities Total132.6M104.1M73.0M51.9M58.6M77.5M
Inventory11.9M10.5M27.7M39.3M50.9M53.4M
Other Current Assets14.1M31.9M35.7M23.2M10.2M15.3M
Other Stockholder Equity49.8M45.6M55.4M40.2M29.0M27.6M
Total Liab227.5M190.5M170.3M147.1M141.3M158.9M
Total Current Assets245.7M295.2M275.2M252.6M250.2M179.7M
Short Term Debt16.8M14.0M14.7M14.8M9.8M9.4M
Intangible Assets3.9M3.2M2.6M1.9M1M950K
Short Term Investments99.3M88.5M32.6M102.5M91.3M48.4M
Current Deferred Revenue52.2M39.6M26.1M25.9M29.8M19.8M
Net Receivables26.7M78.9M29.3M27.6M34.7M31.2M
Other Assets37.9M33.7M30.6M(703K)(808.5K)(768.0K)
Accumulated Other Comprehensive Income14K38K19K15.0K13.5K12.8K
Other Liab2.0M92.7M68.8M45.1M51.8M40.3M
Net Tangible Assets10.5M101.7M176.8M221.8M255.0M267.8M
Deferred Long Term Liab5.2M2.8M2.1M1.4M1.3M1.2M
Property Plant Equipment25.6M24.7M26.9M36.9M42.5M31.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pharma Stock Analysis

When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.